Overview
Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells
Takeshi Kita ,
Yasuaki Hata ,
Muneki Miura ,
Shuhei Kawahara ,
Shintaro Nakao and
Tatsuro Ishibashi
From the Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Address correspondence and reprint requests to Yasuaki Hata, MD, PhD, Department of Ophthalmology, Graduate School of Medical
Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka 812-8582, Japan. E-mail: hatachan{at}med.kyushu-u.ac.jp
Abstract
Connective tissue growth factor (CTGF) level is elevated in eyes with proliferative vitreoretinal diseases, such as proliferative
diabetic retinopathy and proliferative vitreoretinopathy (PVR), as we previously reported, but its functional characteristics
on vitreoretinal cells are yet to be clarified. In this study, we demonstrated a growth-promoting effect of CTGF on cultured
hyalocytes and bovine retinal pigment epithelial cells (BRPEs) with the induction of p44/p42 mitogen-activated protein kinase
phosphorylation and [ 3 H]thymidine incorporation. CTGF also stimulated the synthesis of fibronectin by hyalocytes and BRPEs without significant effect
on collagen gel contraction by these cells. On the other hand, CTGF had no direct effects on the proliferation, migration,
or in vitro tube formation by vascular endothelial cells. Nevertheless, CTGF promoted vascular endothelial growth factor (VEGF)
gene expression by hyalocytes and BRPEs. Although the concentrations of both CTGF and VEGF in the human vitreous samples with
proliferative vitreoretinal diseases were elevated, there was no significant correlation between these concentrations. These
findings indicate that CTGF appears to be involved in the formation of proliferative membranes without direct regulation of
their cicatricial contraction in the pathogenesis of proliferative vitreoretinal diseases. Whereas CTGF might have no direct
effects or minimal effects, if any, on retinal neovascularization, it is possible that CTGF has indirect effects by modulating
the expression of VEGF.
BAEC, bovine aortic endothelial cell
BREC, bovine retinal capillary endothelial cell
BRPE, bovine retinal pigment epithelial cell
CTGF, connective tissue growth factor
DMEM, Dulbecco's modified Eagle's medium
FBS, fetal bovine serum
HUVEC, human umbilical vein endothelial cell
MAPK, mitogen-activated protein kinase
PDR, proliferative diabetic retinopathy
PVR, proliferative vitreoretinopathy
REC, retinal capillary endothelial cell
RPE, retinal pigment epithelial cell
RRD, rhegmatogenous retinal detachment
TGF-β, transforming growth factor-β
VEGF, vascular endothelial growth factor
Footnotes
Published ahead of print at http://diabetes.diabetesjournals.org on 15 February 2007. DOI: 10.2337/db06-1644.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Accepted February 5, 2007.
Received November 23, 2006.
DIABETES